IQVIA Stock Jumps 5.8% After Baird Raises Price Target to $249

Analyst
โดย Yahoo Finance·Read original
Summary · why it matters

Shares of IQVIA jumped 5.8% in afternoon trading after Baird raised its price target on the stock to $249 from $230 and designated it a 'bullish Fresh Pick'. The firm maintained its 'Outperform' rating, citing the clinical trials market's transformation driven by artificial intelligence, where IQVIA is seen as a key player poised to benefit from the industry's shift toward AI-integrated solutions.

Impact on stocks 1

Biotech & Genomic Medicine▲ · 1 stocks
IQVIA Holdings Inc
IQV
▲ PositiveCapitalrelevance

Baird raised price target to $249 and designated IQVIA a 'bullish Fresh Pick' with Outperform rating

© 2026 MarketDXNews